Louisiana State Employees Retirement System held its stake in Orthofix International N.V. (NASDAQ:OFIX) during the second quarter, Holdings Channel reports. The firm owned 7,300 shares of the medical device company’s stock at the end of the second quarter. Louisiana State Employees Retirement System’s holdings in Orthofix International N.V. were worth $339,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in Orthofix International N.V. during the fourth quarter valued at $5,664,000. Teachers Advisors LLC boosted its stake in Orthofix International N.V. by 18.2% in the fourth quarter. Teachers Advisors LLC now owns 35,600 shares of the medical device company’s stock valued at $1,288,000 after buying an additional 5,489 shares during the last quarter. Capstone Asset Management Co. bought a new stake in Orthofix International N.V. during the first quarter valued at $204,000. Nationwide Fund Advisors boosted its stake in Orthofix International N.V. by 94.7% in the first quarter. Nationwide Fund Advisors now owns 24,441 shares of the medical device company’s stock valued at $932,000 after buying an additional 11,888 shares during the last quarter. Finally, Old Mutual Global Investors UK Ltd. boosted its stake in Orthofix International N.V. by 210.8% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 8,059 shares of the medical device company’s stock valued at $307,000 after buying an additional 5,466 shares during the last quarter. Institutional investors and hedge funds own 97.31% of the company’s stock.

Shares of Orthofix International N.V. (NASDAQ:OFIX) traded down 0.3795% on Wednesday, reaching $48.0071. 10,157 shares of the company’s stock were exchanged. The firm’s 50-day moving average price is $45.74 and its 200 day moving average price is $41.14. The company has a market cap of $872.29 million, a price-to-earnings ratio of 112.4288 and a beta of 0.25. Orthofix International N.V. has a 12 month low of $32.51 and a 12 month high of $49.60.

Orthofix International N.V. (NASDAQ:OFIX) last announced its earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The firm had revenue of $108.90 million for the quarter, compared to analyst estimates of $102.94 million. During the same quarter in the prior year, the business posted $0.41 EPS. The business’s revenue was up 4.6% compared to the same quarter last year. Equities research analysts predict that Orthofix International N.V. will post $1.57 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/orthofix-international-n-v-ofix-position-maintained-by-louisiana-state-employees-retirement-system/1496024.html.

OFIX has been the subject of several research reports. Zacks Investment Research upgraded shares of Orthofix International N.V. from a “sell” rating to a “hold” rating in a research note on Wednesday, May 3rd. SunTrust Banks, Inc. initiated coverage on shares of Orthofix International N.V. in a research note on Tuesday, May 23rd. They issued a “buy” rating and a $49.00 target price for the company. Ladenburg Thalmann Financial Services initiated coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. They issued a “buy” rating and a $53.25 target price for the company. Langenberg & Company reiterated a “buy” rating and issued a $53.25 target price on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. Finally, BTIG Research initiated coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 21st. They issued a “buy” rating and a $52.00 target price for the company. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $52.75.

In other Orthofix International N.V. news, insider Raymond Fujikawa sold 6,364 shares of the stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $47.06, for a total transaction of $299,489.84. Following the transaction, the insider now owns 31,084 shares in the company, valued at approximately $1,462,813.04. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 5.60% of the company’s stock.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International N.V. (NASDAQ:OFIX).

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.